Because FAS and FASL-mediated cell death machinery are involved in irradiation- or genotoxin-induced cell death of GBM cells [37,100,101], these findings suggest that PTPN13 acts as an oncogene in GBM cells by inhibiting therapy-induced GBM cell death. The gene discussed is PTPN13; the disease is glioblastoma.